Prognia
Drug Database
🇺🇸US · FDA ApprovedPrescriptionANDA218984-001

ACAMPROSATE CALCIUM

Manufacturer: APPCO

FDA Approval: 16/03/2026

Route: ORAL · TABLET, DELAYED RELEASE

Active Ingredients

ACAMPROSATE CALCIUM 333MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ACAMPROSATE CALCIUM — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.